tag:blogger.com,1999:blog-10194995834086788212024-02-29T03:18:21.670-08:00Pharmaceutical News LiveLive News from Pharmaceutical Sector from around the globe...Unknownnoreply@blogger.comBlogger2413125tag:blogger.com,1999:blog-1019499583408678821.post-66659194374823417052024-02-29T03:17:00.000-08:002024-02-29T03:17:32.858-08:00Nicaragua becomes first Spanish-speaking nation to recognize Indian Pharmacopoeia <p style="text-align: justify;"></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg2bD16mUUonGpqfATDPbN7IQSYQHu2D5DWoOC-RTjGFBbMtGKacM2NEntkOdclVh4HRmqvNbxOYyhJT0FoFlT4pyAILRyG4NFCixeGUqk8qdPinicAlK7ExIk4R2NR8_6L0Mb4m0k426KeHS4wHEH5iu99F2RF74tzq1Gwp-aasjT0tdvUgVAUuTq8RYg/s640/Untitled.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="353" data-original-width="640" height="354" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg2bD16mUUonGpqfATDPbN7IQSYQHu2D5DWoOC-RTjGFBbMtGKacM2NEntkOdclVh4HRmqvNbxOYyhJT0FoFlT4pyAILRyG4NFCixeGUqk8qdPinicAlK7ExIk4R2NR8_6L0Mb4m0k426KeHS4wHEH5iu99F2RF74tzq1Gwp-aasjT0tdvUgVAUuTq8RYg/w640-h354/Untitled.png" width="640" /></a></div><br />In a significant diplomatic development, Nicaragua has become the first Spanish-speaking nation to officially recognize the Indian Pharmacopoeia (IP) or Indian Pharma standards. This development follows the signing of a Memorandum of Understanding (MoU) on Pharmacopoeia Cooperation between the governments of India and Nicaragua.<p></p><p style="text-align: justify;">The ceremony, held in Nicaragua's capital, saw the signing of the MoU by Dr Sumit Seth, the Indian Ambassador to Nicaragua, and Dr Martha Reyes, Nicaragua's Minister of Health.</p><p style="text-align: justify;">The Memorandum of Understanding underscores a shared commitment to collaboration in the regulation of medicines, marking a crucial step towards international harmonization of pharmaceutical standards.</p><p style="text-align: justify;">The move is expected to foster stronger ties between the two nations in the areas of healthcare, encouraging the exchange of expertise and resources for improved medical standards.</p><p style="text-align: justify;">The Indian Pharmacopoeia (IP), compiled by the Indian Pharmacopoeia Commission (IPC) under the Ministry of Health & Family Welfare in India, serves as the official compendium of standards for drugs.</p><p style="text-align: justify;">With the latest edition published in 2022, the IP comprises over 3,000 monographs, establishing precise limits and testing methods for both raw materials and finished pharmaceutical products.</p><p style="text-align: justify;">The legal significance of the IP within India, enshrined in the Second Schedule of the Drugs & Cosmetics Act, 1940, necessitates adherence to its standards for all imported, manufactured, and distributed drugs within the country.</p><p style="text-align: justify;">This recognition by Nicaragua adds another feather to the IP's cap, solidifying its global standing and influence.</p><p style="text-align: justify;">The IPC, an autonomous institute with the mandate to publish the IP at regular intervals has created a key document as a benchmark for pharmaceutical standards.</p><p style="text-align: justify;">The IP's recognition by Nicaragua follows suit with five other countries - Afghanistan, Ghana, Nepal, Mauritius, and Suriname - who have already acknowledged its importance in ensuring the quality and safety of medicinal products.</p><p style="text-align: justify;">The formal recognition of the Indian Pharmacopoeia serves as a testament to the growing importance of standardized regulations in the global pharmaceutical landscape.</p>Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-34481832464450098502023-08-06T22:37:00.002-07:002023-08-06T22:39:49.402-07:00UP Released Pharma & Medical Devices Industry Policy, 2023<p style="text-align: justify;"></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEix15k4uBcGFzRuk2S1XWPf5Al09_UfdcLTLIHF66Sms5fN6d3k42i6DPbF_2du47tpQYHfPJghTgFi05BLyn9ncHrcmt0TVoBnwEBeDyw5zHxQpohURv_0Svx-51Rx39wgtc61TFYaagc2qOcSbUyfsvd1gKwlRgzfKwLWC-ubONyWqmdklZ-jt1vFG5Y/s1280/UP_Pharma_Policy.png" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="720" data-original-width="1280" height="225" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEix15k4uBcGFzRuk2S1XWPf5Al09_UfdcLTLIHF66Sms5fN6d3k42i6DPbF_2du47tpQYHfPJghTgFi05BLyn9ncHrcmt0TVoBnwEBeDyw5zHxQpohURv_0Svx-51Rx39wgtc61TFYaagc2qOcSbUyfsvd1gKwlRgzfKwLWC-ubONyWqmdklZ-jt1vFG5Y/w400-h225/UP_Pharma_Policy.png" width="400" /></a></div><br />The Uttar Pradesh government has issued the Pharmaceutical and Medical Devices Industry Policy, 2023, which includes provisions for a single window clearance under the direct supervision of the Chief Minister's office, time-bound clearances, pre-consultation of project plans by the regulator, and a dedicated technical advisory body for guidance and support, in addition to incentives for pharma parks, manufacturing units, and support for start-ups and marketing activities.<p></p><p style="text-align: justify;">The State will have a single window clearance system, which will be directly supervised by the Chief Minister's office, as part of its efforts to promote ease of doing business.</p><p style="text-align: justify;">The regulations will ensure timely delivery of services, clearances, permissions, and permits as part of making time bound clearances.</p><p style="text-align: justify;">The Food and Drug Administration (FSDA) will appoint a nodal officer to help investors in obtaining the pollution No Objection Certificate (NOC) and other certificates required to develop pharmaceutical facilities.</p><p style="text-align: justify;">The FSDA team will review the project dossier and building plan supplied by the investors to determine the feasibility of the project, and a Letter of Comfort will be issued to the investor following satisfactory scrutiny of the dossier.</p><p style="text-align: justify;">The government will also set up the Uttar Pradesh Pharmaceutical Development Cell (UPPDC) as an advisory body for technical guidance and support.</p><p style="text-align: justify;">The cell will be chaired by the Additional Chief Secretary or Principal Secretary of the Department of FSDA and consist of representatives from concerned departments and experts from different areas of pharmaceutical and biotechnology, while representatives from the industry associations will be invited members. The matter referred by the regulatory committees and others will be taken up by the Cell from time to time and it will also facilitate the development of a data bank and resource centres apart from other supports.</p><p style="text-align: justify;">There will also be an Empowered Committee, chaired by the Chief Secretary, to oversee the policy's development and the scheme's implementation. It would also have the jurisdiction to approve proposals for mega projects (projects with a capital investment of more than Rs. 100 crore). Representatives from industry associations will also be invited members.</p><p style="text-align: justify;">The policy aims to revamp the State's pharmaceutical and medical device industry by encouraging local production, promoting research and development and improving the availability of affordable medicines to the citizens.</p><p style="text-align: justify;">The policy focuses on creating a conducive environment for the growth of the pharmaceutical industry in the state aiming to attract investments in the sector by providing a range of incentives such as subsidies and land allocation for setting up manufacturing units.</p><p style="text-align: justify;">It also intends to create a robust ecosystem for research and development by setting up State-of-the-art facilities and collaborating with academic institutions and research institutes.</p><p style="text-align: justify;">Around 217 companies have proposed to invest nearly Rs. 28,500 crore in the pharmaceutical and medical devices sector. These investments are expected to create nearly 57,000 job opportunities, boost the local economy, and contribute to the growth of the sector. The State also has a robust manpower availability for the industry, it added.</p>Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-69824678398916596292023-02-04T02:55:00.004-08:002023-02-04T03:02:18.981-08:00CDSCO Suspended Manufacturing of Eye Drops of Global Pharma, Chennai<p style="text-align: justify;"></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhi0jCUFOHt0n8yE4RP6IuzT4-eyTSF8kE-cCUttMKMfD7lT52kjc7WxmsPUnJcZk0XAAc_YcVn4AOTLImMDQHhi4ft7gNs9FwP55RvpgYjBSLI_KMLnPefEVYXwTK2R7HyCbv9-JPtf9X8nhg7A2XER56xhA-OnBvfFbJva8gnCBZS3_4Pes7pYFxN/s499/GHC.png" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="281" data-original-width="499" height="225" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhi0jCUFOHt0n8yE4RP6IuzT4-eyTSF8kE-cCUttMKMfD7lT52kjc7WxmsPUnJcZk0XAAc_YcVn4AOTLImMDQHhi4ft7gNs9FwP55RvpgYjBSLI_KMLnPefEVYXwTK2R7HyCbv9-JPtf9X8nhg7A2XER56xhA-OnBvfFbJva8gnCBZS3_4Pes7pYFxN/w400-h225/GHC.png" width="400" /></a></div><br />India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after US FDA allegedly linked 55 adverse events cases with contaminated eye drops.<p></p><p style="text-align: justify;">The samples were taken for analysis from four batches of control samples. The sample of raw material Carboxy Methyl Cellulose Sodium was also taken: Sources on 'Artificial Tears' eyedrops</p><p style="text-align: justify;">The manufacturer was instructed to stop the manufacturing activities of all the products under the category of ophthalmic preparation till the completion of the investigation</p><p style="text-align: justify;">During the investigation by senior drug inspectors, it was found that Chennai-based firm Global Health Care Pvt Ltd had exported two consignments of 24 batches of 'Artificial Tears' to USA which were manufactured in 2021 and 2022</p><p style="text-align: justify;">Global Pharma initiated a voluntary recall at the consumer level of all unexpired lots of EzriCare Artificial Tears and Delsam Pharma's Artificial Tears.</p>Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-61550681047885645002023-02-02T19:48:00.004-08:002023-02-02T19:48:26.602-08:006 months jail if TDS on Free Samples to Doctors not Deposited<p style="text-align: justify;"></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhVZyMSKaWWWsP9wmBXsbwY8fgsJvmJVCJvRZqS21a9WBdL0ew5TsxScvQK96mliHGKcxOWCqg4JxZRjXylJOIvgNxj3JfJY-r6stiK4s34FKSGRFI2R1MCWgWkTyFWIDkMiX6pkmfp6GRZkL1-9CKIw0Ns3YqMnvJushMnVWmJ6jz-pCBZMs61mHZU/s503/tax.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="332" data-original-width="503" height="264" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhVZyMSKaWWWsP9wmBXsbwY8fgsJvmJVCJvRZqS21a9WBdL0ew5TsxScvQK96mliHGKcxOWCqg4JxZRjXylJOIvgNxj3JfJY-r6stiK4s34FKSGRFI2R1MCWgWkTyFWIDkMiX6pkmfp6GRZkL1-9CKIw0Ns3YqMnvJushMnVWmJ6jz-pCBZMs61mHZU/w400-h264/tax.png" width="400" /></a></div><br />The Union Government has recently clarified that failing to deduct and pay 10 percent TDS on the value of freebies received by doctors, as required under Section 194R (TDS on benefit or perquisite in respect of business or profession) in the Income-tax Act, 1961, will attract jail term for up to 6 months and a sum of penalty.<p></p><p style="text-align: justify;">This came during the budget for the year 2023-24, wherein, various amendments have been proposed for the taxpayers by the Union Finance Minister Nirmala Sitharaman.</p><div><div style="text-align: justify;">Last year, the Central Board of Direct Taxes (CBDT) had issued the guidelines clarifying the applicability of the newly inserted section 194R in the Income-tax Act, 1961 effective July 1, 2022.</div><div style="text-align: justify;">The new section 194R mandates a person, who is responsible for providing any benefit or perquisite to a resident, to deduct tax at source @ 10% of the value or aggregate of value of such benefit or perquisite, before providing such benefit or perquisite. The benefit or perquisite may or may not be convertible into money but should arise either from carrying out of business, or from exercising a profession, by such resident.</div></div><div style="text-align: justify;"><br /></div><div style="text-align: justify;">However, the provisions for penalty and prosecution did not clearly mandated penalty or prosecution for a person who does not pay or fails to ensure compliance to the said Section.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify;">To ensure highest level of compliance and adherence to Section 194R, lately, the Government has proposed to amend section 271C and section 276B of the Act by incorporating penalty and prosecution provisions pursuant to non-adherence of Section 194R (TDS on benefit or perquisite in respect of business or profession) effective from the 1st day of April, 2023.</div><div style="text-align: justify;"><br /></div><div><div style="text-align: justify;">With this, all Assessess need to be vigilant and cannot take these provisions lightly.</div><div style="text-align: justify;">Section 271C is proposed to be amended to state that where a person fails to pay or ensure payment as required under Section 194R, then Section 271C which is a penalty provision, can get attracted.</div><div style="text-align: justify;">Further, Section 276B refers to prosecution and corresponding amendments for non-compliance of Section 194R and Section 194S have been proposed in prosecution provisions as well.</div></div><div style="text-align: justify;"><br /></div><div><div style="text-align: justify;">After section 276A of the Income-tax Act, the following section shall be inserted, namely: —</div><div style="text-align: justify;">"276B. If a person, without reasonable cause or excuse, fails to deduct or after deducting fails to pay the tax as required by or under the provisions of sub-section (9) of section 80E or Chapter XVII-B, he shall be punishable with rigorous imprisonment for a term which may extend to six months, and shall also be liable to fine which shall be not less than a sum calculated at the rate of fifteen per cent, per annum on the amount of such tax from the date on which such tax was deductible to the date on which such tax is actually paid."</div><div style="text-align: justify;">The move is going to cast a severe dent on the traditional pharma marketing practices across the country. The applicability of the new provision is likely to make handing out of freebies and even free samples to doctors less attractive, which comes as a major setback for pharma companies.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify;">Medical Dialogues team had earlier reported that the new Finance Budget had clarified that any claims of expenses incurred while providing benefits to others that violate the provisions of Indian Medical Council Regulations, 2002 shall be inadmissible for a tax deduction. With this, pharma companies can no longer claim such expenditure as a business deduction, which in turn will jack up the taxable profits of a pharma company. The Government has also been considering to make the UCPMP mandatory for all pharmaceutical companies.</div></div><div style="text-align: justify;"><br /></div>Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-77358315291646191262023-01-30T19:41:00.003-08:002023-01-30T19:41:33.696-08:00Zero observations of USFDA for Gland Pharma's Visakhapatnam facility<p style="text-align: justify;"></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjQYP7xj61ixocyeI5xTISOKUqlaG0eXxOmLwJkwo6uXai-4-7WQWDtys6KGCAEqipY0Ri9qPkU5HJ-YZsii17TkEM3PzurrBMXIabyRFcIGZSHcjQ4uW0mtfThRvNb86Rjo7MIEX5wXkKzOgKbNd4JmfjKR2PzJBiZREjV9-QhK66w2G4JMZNrzWJC/s272/Gland.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="150" data-original-width="272" height="221" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjQYP7xj61ixocyeI5xTISOKUqlaG0eXxOmLwJkwo6uXai-4-7WQWDtys6KGCAEqipY0Ri9qPkU5HJ-YZsii17TkEM3PzurrBMXIabyRFcIGZSHcjQ4uW0mtfThRvNb86Rjo7MIEX5wXkKzOgKbNd4JmfjKR2PzJBiZREjV9-QhK66w2G4JMZNrzWJC/w400-h221/Gland.png" width="400" /></a></div><br />Gland Pharma said that the United States Food and Drug Administration (US FDA) had conducted an inspection at the company's API Facility at JNPC, Visakhapatnam, from 23rd January 2023 to 27th January 2023.<p></p><p style="text-align: justify;">The drug maker further informed that the said inspection has been completed with 'zero' observations.</p><p style="text-align: justify;">Hyderabad-based Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India, and other markets.</p><p style="text-align: justify;">The pharmaceutical company's consolidated net profit dropped 15% to Rs 231.95 crore on 11.8% decline in net sales to Rs 938.29 crore in Q3 FY23 over Q3 FY22.</p><p style="text-align: justify;">The scrip had advanced 1.16% to end at Rs 1357.10 on the BSE on Friday.</p>Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-53986467555908877722018-03-12T02:25:00.001-07:002018-03-12T02:25:08.906-07:00Labeling Norms For Generic Drugs Changed: Health Minister <div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjK8hS-uMCxdquclhGGa1Q5jAvbmnNYa40iY9qm43C2t3EuHRUVzk6enwqHT6Wn_6fM8NBSmN3VsQYsSIQCC0APBoy_s59RDbJxn8umHYzB8YJScS1BPu_DK-juyXvNaZrAqDXMmecLa5Q/s1600/Ashwani_Choubey.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="360" data-original-width="480" height="480" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjK8hS-uMCxdquclhGGa1Q5jAvbmnNYa40iY9qm43C2t3EuHRUVzk6enwqHT6Wn_6fM8NBSmN3VsQYsSIQCC0APBoy_s59RDbJxn8umHYzB8YJScS1BPu_DK-juyXvNaZrAqDXMmecLa5Q/s640/Ashwani_Choubey.jpg" width="640" /></a></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about the labeling norms for generic drugs.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
In order to ensure that the consumer is well informed about the generic medicine, Ministry of Health and Family Welfare published a draft notification for public comments vide GSR 302 (E) dated 30.03.2017 for amendment of Rule 96 to provide that the proper name of the drugs shall be printed in a conspicuous manner which shall be in the same font but at level two font size larger than the brand name or the trade name, if any. It will come to force after completion of due formalities as per the provisions of the Drugs and Cosmetics Act, 1940.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Indian Drug Manufacturers Association (IDMA) was invited to the stakeholders meeting held on 12.12.2017 in Central Drugs Standard Control Organisation (CDSCO) and they conveyed their inability to attend the meeting. However, they had already provided their suggestions/ comments on the draft notification vide letter dated, 11.05.2017 which has been received in the Ministry.</div>
<div style="text-align: justify;">
<br /></div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-20628246504740646902018-03-05T02:36:00.000-08:002018-03-05T02:36:10.506-08:00#Natco Pharma seeks #USFDA Approval for #Hepatitis Drug<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiI8dviqmXD1FyvjDuLrxFXsd6u38bBZFZ20sZTlu_wmPB5fVmEiHiywgbYp9YYHYsga194diIWzJ-5iCoH5YXAKzRgzpr6b4r36MWMV7Fa8u36PRqsXjFyDazST5FyIyISea-aGhPaRxs/s1600/Natco_ANDA.png" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="300" data-original-width="400" height="300" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiI8dviqmXD1FyvjDuLrxFXsd6u38bBZFZ20sZTlu_wmPB5fVmEiHiywgbYp9YYHYsga194diIWzJ-5iCoH5YXAKzRgzpr6b4r36MWMV7Fa8u36PRqsXjFyDazST5FyIyISea-aGhPaRxs/s400/Natco_ANDA.png" width="400" /></a></div>
<div style="text-align: justify;">
Drug firm Natco Pharma said it has filed an abbreviated new drug application (ANDA) for Sofosbuvir Tablets, 400mg, with the United States Food and Drug Administration (USFDA).</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Sofosbuvir is used for chronic hepatitis C infection and sold globally by Gilead Sciences, Inc, under its brand Sovaldi, Natco Pharma said in a filing to BSE.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The company believes that “they are the first to have filed a substantially complete ANDA containing a Paragraph IV certification for this product and expects to be eligible for 180 days of marketing exclusivity upon receiving final FDA approval,” it added.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
For the 12 months ending December 31, 2017, Sovaldi had US sales of approximately USD 130 million as per Gilead Sciences Inc’s unaudited results released for the year ending December 31, 2017, Natco Pharma said.</div>
<div style="text-align: justify;">
<br /></div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-45762921270970817022018-01-23T02:33:00.000-08:002018-01-23T02:33:08.932-08:00Applications for r-DNA derived Drugs via #Sugam Portal Now<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg4K3e0mRrgm3nHpm0oCI4qWTb1Wk3O-dEAVfN_ARhepdTOFNJbdZeAZa6tx-qUt_bP_OjBCvpvGq6j1UgI9-eOhygYCccQJAU9xZEaEZS7rBOtRWmV3jAGFSxJchRsy_v7S_h6N1cYawE/s1600/Sugam_CDSCO.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="259" data-original-width="355" height="291" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg4K3e0mRrgm3nHpm0oCI4qWTb1Wk3O-dEAVfN_ARhepdTOFNJbdZeAZa6tx-qUt_bP_OjBCvpvGq6j1UgI9-eOhygYCccQJAU9xZEaEZS7rBOtRWmV3jAGFSxJchRsy_v7S_h6N1cYawE/s400/Sugam_CDSCO.jpg" width="400" /></a></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Through a recent notification, CDSCO has said that the filling of application for Clinical Trial, Marketing Authorization, Registration Certificate and Import License for r-DNA Derived Drugs will be initiated with effect from 01.02.2018 in SUGAM portal</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The authority has decided that applications pertaining to Clinical Trial, Marketing Authorization, Registration Certificate and Import License for r-DNA Derived Drugs will be accepted through online mode only from 1st Feb 2018 and no offline applications will be accepted after that.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
On November 14, 2015, the Central Drugs Standard Control Organisation has launched an online portal SUGAM (www.cdscoonline.gov.in) in pursuance of the implementation of E-Governance.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The notice states that a reference is also invited to the stakeholders meeting held on 10.01.2018 wherein it has been agreed upon that, filling of application for Clinical Trial, Marketing Authorization, Registration Certificate and Import License for r-DNA Derived Drugs will be initiated with effect from 01.02.2018 in SUGAM portal.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
In view of above, it has been decided that applications pertaining to Clinical Trial, Marketing Authorization, Registration Certificate and Import License for r-DNA Derived Drugs shall be accepted only through online mode from 1st Feb 2018 and no offline applications will be accepted thereafter.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<a href="https://www.scribd.com/document/369788729/CDSCO-Notice-regarding-Applications-for-r-DNA-derived-Drugs-via-Sugam-Portal-Now" target="_blank"><b>Download </b><span style="text-align: left;"><b>Notification</b></span></a></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-10304079964568893262018-01-19T21:09:00.002-08:002018-01-19T21:09:17.346-08:00#NPPA Sets aside notification on Fixation of #Erythromycin Price <div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiYzri3K60Qf2J0BGwPz-wxw6XPNe8PRjL5wxK7n2On2zHmuOERTj9Qm20czaCYYjV082SN2eemgfzvFymXf8Mcs4zwUTanNIFwBiuyGS_fSSdocTB8_JsQUn3EZ6plA0RfHc923Ozpa_U/s1600/erythromycin_tablet.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="450" data-original-width="600" height="480" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiYzri3K60Qf2J0BGwPz-wxw6XPNe8PRjL5wxK7n2On2zHmuOERTj9Qm20czaCYYjV082SN2eemgfzvFymXf8Mcs4zwUTanNIFwBiuyGS_fSSdocTB8_JsQUn3EZ6plA0RfHc923Ozpa_U/s640/erythromycin_tablet.jpg" width="640" /></a></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India has set aside its notification of dated 11th May 2017 in which the regulator had fixed the ceiling price of the following formulations with immediate effect.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
1. Erythromycin Estolate Tablet 250mg</div>
<div style="text-align: justify;">
2. Erythromycin Estolate Tablet 500mg</div>
<div style="text-align: justify;">
3. Erythromycin Estolate Syrup 125 mg / 5 ml</div>
<div style="text-align: justify;">
4. Chloroquine Phosphate Injection 40 mg / ml (64.5mg eq. to 40mg chloroquine)</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
On 11th May 2017, NPPA had fixed the prices of the Erythromycin Estolate Tablet 250mg at Rs 3.02 for 1 tablet, Erythromycin Estolate Tablet 500mg at Rs 5.86 for 1 tablet, Erythromycin Estolate Syrup 125 mg/5 ml at Rs 0.53 for 1ml, and Chloroquine Phosphate Injection 40 mg / ml (64.5mg eq. to 40mg chloroquine) at Rs 1.31 for 1ml.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
However, challenging the said notification, Alembic Pharmaceuticals Limited filed a petition under paragraph 31 of the Drugs (Prices Control) Order, 2013</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The petitioner contended that Erythromycin formulations namely Erythromycin Tablet 500mg, Erythromycin, Tablet 250mg and Erythromycin Syrup 125mg/5ml have been shifted to Non scheduled by the Government on 10th March 2016 and NPPA has been directed to regulate the Scheduled drugs shifted to Nonscheduled category as NON-SCHEDULED drugs under para 20 of DPCO, 2013.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Furthermore, the petitioner contended that NPPA had fixed the ceiling prices of above said Non-scheduled formulations referring to the paras 4,10,11,14,16,17 and 18 of DPCO, 2013, which is inconsistent with provisions of DPCO, 2013.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
After examination government had directed NPPA to issue revised SO within one month by excluding the formulations Erythromycin Estolate Tablets 250mg, Erythromycin Tablets 500mg and Erythromycin Syrup 125mg.5ml., which have since been shifted to non-scheduled category under Schedule-I of NLEM, 2015, and re-fixing the ceiling price of only one formulation, viz. Chloroquine Phosphate Injection 40mg/ml.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Following the notification of the government, NPPA re-examined and submitted the report to the government after that DoP stated that</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
“NPPA is hereby directed to set aside the SO 1526(E), dated 11.5.2017, as all the four formulations, i.e. Erythromycin Estolate Tablets 250 mg, Erythromycin Estolate 500mg, Erythromycin Estolate Syrup 125mg/5ml and Chloroquine Injection 40mg/ml, have been shifted to non-scheduled category vide SO 701(E), dated 10.3.2016.”</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Below is the attachment for the same.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<a href="http://www.nppaindia.nic.in/ceiling/press16jan18/Price_Order.pdf">http://www.nppaindia.nic.in/ceiling/press16jan18/Price_Order.pdf</a></div>
<div style="text-align: justify;">
<br /></div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-17302762543452228562018-01-05T21:15:00.000-08:002018-01-05T21:16:22.999-08:00Voveran 1ml causes Kidney Damage: Health Ministry Recommends Toxicity Check<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi_bjSEv7hslezqm_XJOkJTuQhakoKSYxOkqeWc5i1MAMGSR1X8AdH7zWe2A15TochTLjlmAXOsH4AjW8oDhU9zqwCPX38TrydNJVTbiqdnSn_qdEOrtRNseDu0o_r0oN6-EijcRo46TyE/s1600/Voveran+1+ml.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="600" data-original-width="600" height="400" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi_bjSEv7hslezqm_XJOkJTuQhakoKSYxOkqeWc5i1MAMGSR1X8AdH7zWe2A15TochTLjlmAXOsH4AjW8oDhU9zqwCPX38TrydNJVTbiqdnSn_qdEOrtRNseDu0o_r0oN6-EijcRo46TyE/s400/Voveran+1+ml.png" width="400" /></a></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name Voveran 1 ml Injection.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Troikaa Pharmaceuticals had alleged that the painkiller injection diclofenac Sodium 75 mg/ml contains Transcutol, which damages kidneys and filed a petition in Delhi High Court against the granting of manufacturing licenses for the painkiller and allowing its marketing by Novartis AG.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Troikaa has developed and sells Diclofenac Sodium 75 mg/ml injection under the brand name ‘Dynapar AQ’, which is patented globally.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The petition stated that Themis to avoid patent infringement, is manufacturing a different version of its Diclofenac Sodium 75 mg/ml injection and Novartis is marketing it.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The petition further stated that Themis and Novartis have conveniently ignored the fact that Transcutol P is not recommended for parenteral use Regulatory bodies in US, Europe, and other parts of the world do not permit it’s parenteral use, as it is known to cause injury to kidneys.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
During the hearing, the court had formed an expert panel to review the safety of Transcutol-P who gave their recommendations in favor of Troikaa. Novartis then approached the health ministry after which the second panel was formed under the Directorate General of Health Services. The second panel gave their decision in favor of Novartis.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Another panel was formed under Girish Sahni, director general, Centre of Scientific and Industrial Research (CSIR), in May after the contradictory reports on Troikaa’s allegations.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The which submitted its report on 29 December, endorsed Troikaa’s submissions. The committee also did not find any evidence supporting the claim of Novartis and Themis, two people aware of the matter said, adding that the panel has recommended that Transcutol-P be independently tested for toxicity. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Sahni panel, A spokesperson for Themis maintained that product is absolutely safe and told , “Post our meeting with the committee sometime in July 2017, we do not have any further status on the subject from authorities, hence unable to comment.”</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-7733721878872756042018-01-05T00:02:00.002-08:002018-01-05T00:02:28.560-08:00#USFDA Warning Letter to German Drug Firm for Baddi Plant<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgRlrZo5-FuqbAOkqawI-ZjJgwAWPgfkwfS2c6vgphIaKlL4ryTEi72dtoAI15hRNuWTH_CkGiPUBiD9Lckd-mb9iDnqSCXhnLU8g-pd7zyeLvofzi7eLjfwpfrBbAwNVvZR_HHksOTqOo/s1600/Fresenius+Kabi+AG.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="598" data-original-width="966" height="396" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgRlrZo5-FuqbAOkqawI-ZjJgwAWPgfkwfS2c6vgphIaKlL4ryTEi72dtoAI15hRNuWTH_CkGiPUBiD9Lckd-mb9iDnqSCXhnLU8g-pd7zyeLvofzi7eLjfwpfrBbAwNVvZR_HHksOTqOo/s640/Fresenius+Kabi+AG.JPG" width="640" /></a></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for</div>
<div style="text-align: justify;">
lapses at its drug manufacturing facility at Baddi in Himachal Pradesh.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
In a letter to the company’s CEO Mats Henriksson summarising violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals, United States Food and Drug Administration (USFDA) said it had conducted inspection of the Baddi facility from April 6 to 14, 2017.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
“Your firm failed to thoroughly investigate any unexplained discrepancy or failure of a batch or any of its components to meet any of its specifications, whether or not the batch has already been distributed,” the health regulator said.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
While saying that it had reviewed company’s May 10, 2017, response in detail and acknowledges receipt of its subsequent correspondence, USFDA asked the drug firm to provide plans and procedures to ensure that future sterility failure investigations included a more thorough review of long-term trends.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The regulator also asked Fresenius Kabi AG to ensure sufficient investigation of potential vulnerabilities in the manufacturing operation and potential correlations with past incidents.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The letter also said that in an inspection from May 14 to 22, 2015, FDA had cited a similar CGMP observation in which the company invalidated sterility test failures without adequately investigating the root causes, and failed to take timely and appropriate corrective actions.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
“Although you proposed remediations in your responses following the 2015 inspection, and discussed these plans during a 2016 regulatory meeting with the Agency, our current inspection found that your facility’s oversight and control over the manufacture of drugs remains deficient,” it added.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Recommending engaging of CGMP Consultant, USFDA said based upon the nature of the violations it strongly recommended engaging a consultant to assist the company in meeting CGMP requirements.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The regulator said until the company corrects all violations completely and “we confirm your compliance with CGMP, FDA may withhold approval of any new applications or supplements listing your firm as a drug manufacturer.”</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Failure to correct these violations may also result in FDA refusing admission of articles manufactured at Fresenius Kabi Oncology at Baddi in the United States, USFDA said.</div>
<div style="text-align: justify;">
<br /></div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-11827797804997384002017-11-25T03:09:00.000-08:002017-11-25T03:09:27.643-08:0051 Essential Drugs under #NPPA Price cap,check out details<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhjhe3NOPzgnWWKfbpGVwyDOw3lFP-gCR21TyKiAu7M-zpmzHumCnhGGNfrrK2KZM0WzwcHLyE2c0cRVSsZFkiqTZ8PzHuFz5o8sOKyT0FcAG1INnU1v-zhyrii5QXClkrVrNInPhkBvWA/s1600/NPPA.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="229" data-original-width="326" height="224" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhjhe3NOPzgnWWKfbpGVwyDOw3lFP-gCR21TyKiAu7M-zpmzHumCnhGGNfrrK2KZM0WzwcHLyE2c0cRVSsZFkiqTZ8PzHuFz5o8sOKyT0FcAG1INnU1v-zhyrii5QXClkrVrNInPhkBvWA/s320/NPPA.jpg" width="320" /></a></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
National drug pricing regulator NPPA on Friday said it has capped prices of 51 essential formulations, including those used for the treatment of cancer, pain, heart conditions and skin problems.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The prices have been slashed in the range of 6 to 53 percent.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
In separate notifications, the drug price regulator said it has notified ceiling prices of 13 formulations while revising the same for 15 formulations.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Moreover, retail prices of 23 essential formulations have also been notified, National Pharmaceutical Pricing Authority (NPPA) said.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Drugs whose ceiling prices have been capped includes colon or rectal cancer treatment drug oxaliplatin (injection 100mg), Japanese encephalitis vaccine and measles rubbela vaccine.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
On the other hand, ceiling prices of drugs including anesthetic sevoflurane, Phytomenadione (Vitamin K1) and tuberculosis prevention medicine BCG vaccine have been revised.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
According to highly placed sources in NPPA, the reduction in prices following the latest exercise will range between 6- 53 percent.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
NPPA fixes ceiling price of essential medicines of Schedule I under the Drugs (Prices Control) Order (DPCO) 2013.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
In respect of medicines that are not under price control, manufacturers are allowed to increase the maximum retail price by 10 percent annually.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The calculation of essential drugs is based on the simple average of all medicines in a particular therapeutic segment with sales of more than 1 percent.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Set up in 1997, NPPA has been entrusted with the task of fixation/revision of prices of pharma products, enforcement of provisions of DPCO and monitoring of prices of controlled and decontrolled drugs.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Following are the details:</div>
<div style="text-align: justify;">
<br /></div>
<table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; mso-yfti-tbllook: 1184; width: 0px;">
<tbody>
<tr>
<td style="border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Sl. No.</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Name of the Scheduled</span></strong><b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><br />
<strong>Formulation</strong></span></b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Dosage form & Strength</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Unit<o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Ceiling Price</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
<div class="MsoNormal" style="margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt;">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt;">(Rs.)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt;"><o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(1)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(2)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(3)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(4)<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(5)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Oxaliplatin<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Injection 100mg (as licensed)<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each Pack<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">4055.10<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">2.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Acetylsalicylic acid<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Effervescent/ Dispersible/ Enteric
coated Tablet 100 mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 Tablet<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">0.1625<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">3.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Japanese Encephalitis Vaccine<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">4mcg to 6mcg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each Pack<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">632.95<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">4.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Japanese Encephalitis Vaccine<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">up to 3mcg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each Pack<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">482.22<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">5.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Measles Rubbela Vaccine<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173"></td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each Pack<br />
(0.5ml)<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">80.22<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">6.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Surfactant<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Suspension for intratracheal
instillation (As liensed)<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Per mg of Phospholipids in the
pack<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">60.69<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">7.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Sevoflurane<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Inhalation<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 ml<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">24.12<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">8.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Acetylsalicylic acid<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Tablet 325mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 Tablet<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">0.50<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">9.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Desferrioxamine<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Powder for Injection 500mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each pack<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">145.91<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">10.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Oxaliplatin<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Injection 50mg<br />
(as licensed)<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each Pack<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">2303.01<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">11.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Phytomenadione (Vitamin K1)<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Injection 10mg/ml<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 ML<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">43.45<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">12.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Glutaraldehyde<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Solution 2%<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 ML<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">0.05868<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">13.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Anti-D immunoglobulin<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Injection 300mcg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each Pack<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1936.82<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">14.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">BCG vaccine<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173"></td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each Dose<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">4.32<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">15.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Morphine<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">SR Tablet 30 mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 Tablet<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">4.94<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">16<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Alteplase<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Powder for Injection 20 mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each Pack<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">17235.00<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">17.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Alteplase<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Powder for Injection 50 mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each Pack<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">35985.00<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">18.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Gadobenate<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Injection 529 mg/ml<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 ML<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">98.90<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">19.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Haemodialysis fluid<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">As license<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 ML<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">0.03695<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">20.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Furosemide<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Oral liquid 10 mg/ml<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 ML<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">0.29<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">21.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Glucose<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Injection 50%<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 ml<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">0.44<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">22.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Lignocaine (A) + Adrenaline (B)<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Injection 1% (A) + 1:200000 (5
mcg/ml) (B)<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 ML<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">0.41<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">23.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Calcium gluconate<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Injection 100 mg/ml<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 ML<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">0.50<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">24.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Dextran-40<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Injection 10%<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 ML<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">0.38<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">25.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Coagulation factor IX<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Powder for Injection 600 IU<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each Pack<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">11,180.00<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">26.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Digoxin<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Oral liquid 0.05 mg/ml<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 ML<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">0.29<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">27.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Potassium permanganate<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Crystals for topical solution<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 gm<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">0.40<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 35.35pt;" width="47">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">28.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 125.35pt;" width="167">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Pilocarpine<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 129.55pt;" width="173">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Drops 4%<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.9pt;" width="89">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 ML<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 87.95pt;" width="117">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">10.60<o:p></o:p></span></div>
</td>
</tr>
</tbody></table>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; mso-yfti-tbllook: 1184; width: 0px;">
<tbody>
<tr>
<td style="border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Sl.</span></strong><b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><br />
<strong>No.</strong></span></b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Name of the</span></strong><b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><br />
<strong>Scheduled</strong><br />
<strong>Formulation</strong><br />
<strong>/ Brand</strong><br />
<strong>Name</strong></span></b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Strength</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Unit</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Manufacturer &</span></strong><b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><br />
<strong>Marketing</strong><br />
<strong>Company</strong></span></b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Retail</span></strong><b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><br />
<strong>Price (Rs.)</strong></span></b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(1)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(2)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(3)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(4)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(5)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(6)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Sofosbuvir & Velpatasvir<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each film coated tablet
contains: Sofosbuvir 400mg, Velpatasvir 100mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">28 Tablets<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">M/s Hetero Labs Ltd. / M/s Abbott
India Ltd.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">15625.00<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">2.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Sofosbuvir & Velpatasvir<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each film coated
tablet contains: Sofosbuvir 400mg, Velpatasvir 100mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">28 Tablets<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">M/s Hetero Labs Ltd. / M/s Cadila
Healthcare Ltd.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">15625.00<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">3.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Sofosbuvir & Velpatasvir<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each film coated
tablet contains: Sofosbuvir 400mg, Velpatasvir 100mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">28 Tablets<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">M/s Natco Pharma Ltd. /M/s Sun
Pharmaceuticals Industries Ltd.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">15625.00<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">4.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Sofosbuvir & Velpatasvir<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each film
coated tablet contains: Sofosbuvir 400mg,<br />
Velpatasvir 100mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">28 Tablets<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">M/s Natco Pharma Ltd. / M/s Cipla
Ltd.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">15625.00<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">5.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Sofosbuvir & Velpatasvir<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each film coated
tablet contains: Sofosbuvir 400mg,<br />
Velpatasvir 100mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">28 Tablets<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">M/s Natco Pharma Ltd.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">15625.00<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">6.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Sofosbuvir & Velpatasvir<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each film coated tablet
contains: Sofosbuvir 400mg, Velpatasvir 100mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">28 Tablets<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">M/s Natco Pharma Ltd. / M/s Mylan
Pharmaceuticals Pvt. Ltd<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">15625.00<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">7.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Sofosbuvir & Velpatasvir<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each tablet contains:
Sofosbuvir 400mg, Velpatasvir 100mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">28 Tablets<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">M/s Dr. Reddy’s Limited<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">15,625.00<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">8<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Sofosbuvir & Velpatasvir<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each tablet contains: Sofosbuvir
400mg, Velpatasvir 100mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">28 Tablets<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">M/s Hetro Labs Ltd.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">15,625.00<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">9.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Voglibose + Metformin<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each tablet contains: Voglibose
0.2mg, Metformin 500mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 Tablet<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">M/s Lupin Ltd.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">4.84<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">10.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Voglibose + Metformin<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each tablet contains: Voglibose
0.3mg, Metformin 500mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 Tablet<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">M/s Lupin Ltd.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">5.76<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">11.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Voglibose + Metformin + Glimepirid<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each tablet contains: Voglibose
0.2mg, Metformin 500mg, Glimepirid 1mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 Tablet<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">M/s Lupin Ltd.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">7.14<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">12.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Voglibose + Metformin + Glimepirid<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each tablet contains: Voglibose
0.2mg, Metformin 500mg, Glimepirid 1mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 Tablet<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">M/s Sanofi India Ltd.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">7.14<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">13.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Voglibose + Metformin + Glimepirid<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each tablet contains: Voglibose
0.2mg, Metformin 500mg, Glimepirid 1mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 Tablet<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">M/s Biocon Ltd.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">7.14<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">14.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Voglibose + Metformin + Glimepirid<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each tablet contains: Voglibose
0.2mg, Metformin 500mg, Glimepirid 2mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 Tablet<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">M/s Lupin Ltd.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">9.05<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">15.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Voglibose + Metformin + Glimepirid<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each tablet contains: Voglibose
0.2mg, Metformin 500mg, Glimepirid 2mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 Tablet<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">M/s Sanofi India Ltd.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">9.05<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">16.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Voglibose + Metformin + Glimepirid<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each tablet contains: Voglibose
0.2mg Metformin 500mg Glimepirid 2mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 Tablet<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">M/s Biocon Ltd.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">9.05<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">17.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Voglibose + Metformin + Glimepirid<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each tablet contains: Voglibose
0.3mg, Metformin 500mg, Glimepirid 1mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 Tablet<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">M/s Lupin Ltd.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">8.52<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">18.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Voglibose + Metformin + Glimepirid<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each tablet contains: Voglibose
0.3mg, Metformin 500mg, Glimepirid 1mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 Tablet<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">M/s Alembic Ltd.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">8.52<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">19.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Voglibose + Metformin + Glimepirid<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each tablet contains: Voglibose
0.3mg, Metformin 500mg, Glimepirid 2mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 Tablet<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">M/s Lupin Ltd.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">10.46<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.0pt;" width="44">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">20.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 64.95pt;" width="87">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Diclofenac + Tramadol<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 121.2pt;" width="162">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each tablet contains: Diclofenac
75mg, Tramadol 50mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 Tablet<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 79.15pt;" width="106">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">M/s Alembic Ltd.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 80.45pt;" width="107">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">9.73<o:p></o:p></span></div>
</td>
</tr>
</tbody></table>
<div class="MsoNormal" style="background: white; line-height: 18.0pt; margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt;">
<br /></div>
<table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; mso-yfti-tbllook: 1184; width: 0px;">
<tbody>
<tr>
<td style="border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 19.6pt;" width="26">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Sl.</span></strong><b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><br />
<strong>No</strong><br />
<strong>.</strong></span></b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 68.5pt;" width="91">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Name of the Scheduled</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
<div class="MsoNormal" style="margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt;">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt;">Formulation</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt;"><o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 69.9pt;" width="93">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Dosage form & Strength</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 34.05pt;" width="45">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Unit</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.05pt;" width="44">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Ceili ng Price (Rs.)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 71.6pt;" width="96">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Review Order</span></strong><b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><br />
<strong>number and</strong><br />
<strong>date</strong></span></b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Existing SO number and</span></strong><b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><br />
<strong>date</strong></span></b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 82.05pt;" width="109">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Manufacturer &</span></strong><b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><br />
<strong>Marketing Company</strong><br />
<strong>respectively</strong></span></b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 19.6pt;" width="26">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(1)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 68.5pt;" width="91">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(2)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 69.9pt;" width="93">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(3)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 34.05pt;" width="45">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(4)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.05pt;" width="44">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(5)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 71.6pt;" width="96">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(6)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(7)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 82.05pt;" width="109">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(8)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 19.6pt;" width="26">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 68.5pt;" width="91">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Trypsin, Bromelain, Rutoside
Trihydrate, & Diclofenac Sodium (Volitra Enzo) tablet<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 69.9pt;" width="93">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each enteric coated tablet
contains: Trypsin 48mg, Bromelain 90mg, Rutoside Trihydrate 100mg, Diclofenac
Sodium 50mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 34.05pt;" width="45">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 Tablet<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 33.05pt;" width="44">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">13.91<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 71.6pt;" width="96">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">31015/09/2017 -Pricing dated
27.08.2017<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 66.35pt;" width="88">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">4131(E) dated 22.12.2016(at Sl.
No. 5)<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 82.05pt;" width="109">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">M/s Akums Drugs &
Pharmaceuticals Ltd./ M/s Sun Pharmaceuticals Ind. Ltd.<o:p></o:p></span></div>
</td>
</tr>
</tbody></table>
</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; mso-yfti-tbllook: 1184; width: 0px;">
<tbody>
<tr>
<td style="border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 26.85pt;" width="36">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Sl.</span></strong><b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><br />
<strong>No.</strong></span></b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 62.2pt;" width="83">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Name of the Scheduled Formulation</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 68.05pt;" width="91">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Dosage form &</span></strong><b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><br />
<strong>Strength</strong></span></b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: .5in;" width="48">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Unit</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 31.5pt;" width="42">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Ceilin</span></strong><b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><br />
<strong>g</strong><br />
<strong>Price</strong><br />
<strong>(Rs.)</strong></span></b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 1.5in;" width="144">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Review Order</span></strong><b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><br />
<strong>number and</strong><br />
<strong>date</strong></span></b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 112.5pt;" width="150">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Existing SO number</span></strong><b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><br />
<strong>and date</strong></span></b><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 26.85pt;" width="36">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(1)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 62.2pt;" width="83">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(2)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 68.05pt;" width="91">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(3)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: .5in;" width="48">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(4)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 31.5pt;" width="42">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(5)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 1.5in;" width="144">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(6)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 112.5pt;" width="150">
<div class="MsoNormal">
<strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">(7)</span></strong><span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 26.85pt;" width="36">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 62.2pt;" width="83">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Ceftriaxone<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 68.05pt;" width="91">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Powder for Injection 1gm<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: .5in;" width="48">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Each<br />
Pack<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 31.5pt;" width="42">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">48.92<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 1.5in;" width="144">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">31015/59/2017-Pricing dated
10.10.2017<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 112.5pt;" width="150">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">2058(E) dated 30.6.2017 (at Sl.
No. 120)<o:p></o:p></span></div>
</td>
</tr>
<tr>
<td style="border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 26.85pt;" width="36">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">2.<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 62.2pt;" width="83">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Chloroquine<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 68.05pt;" width="91">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">Tablet 150mg<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: .5in;" width="48">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">1 Tablet<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 31.5pt;" width="42">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">0.72<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 1.5in;" width="144">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">31015/32/2017- Pricing dated
24.8.2017<o:p></o:p></span></div>
</td>
<td style="border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .75pt; mso-border-left-alt: solid windowtext .75pt; mso-border-top-alt: solid windowtext .75pt; padding: .75pt .75pt .75pt .75pt; width: 112.5pt;" width="150">
<div class="MsoNormal">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt; mso-fareast-font-family: "Times New Roman";">2059(E) dated 30.6.2017 (at Sl.
No. 23)<o:p></o:p></span></div>
</td>
</tr>
</tbody></table>
</div>
<div style="text-align: justify;">
<div class="MsoNormal" style="background: white; line-height: 18.0pt; margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt;">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt;">Below are the
attachments for the same.<o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 18.0pt; margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt;">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt;"><a href="http://www.nppaindia.nic.in/ceiling/press23oct17/Prices(1).pdf">http://www.nppaindia.nic.in/ceiling/press23oct17/Prices(1).pdf</a><o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 18.0pt; margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt;">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt;"><a href="http://www.nppaindia.nic.in/ceiling/press23oct17/Prices(2).pdf">http://www.nppaindia.nic.in/ceiling/press23oct17/Prices(2).pdf</a><o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 18.0pt; margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt;">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt;"><a href="http://www.nppaindia.nic.in/ceiling/press23oct17/Prices(3).pdf">http://www.nppaindia.nic.in/ceiling/press23oct17/Prices(3).pdf</a><o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 18.0pt; margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt;">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt;"><a href="http://www.nppaindia.nic.in/ceiling/press23oct17/Prices(4).pdf">http://www.nppaindia.nic.in/ceiling/press23oct17/Prices(4).pdf</a><o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 18.0pt; margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt;">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt;"><a href="http://www.nppaindia.nic.in/ceiling/press23oct17/Prices(5).pdf">http://www.nppaindia.nic.in/ceiling/press23oct17/Prices(5).pdf</a><o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 18.0pt; margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt;">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt;"><a href="http://www.nppaindia.nic.in/ceiling/press23oct17/Prices(6).pdf">http://www.nppaindia.nic.in/ceiling/press23oct17/Prices(6).pdf</a><o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 18.0pt; margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt;">
<span style="font-family: "Arial",sans-serif; font-size: 10.5pt;"><a href="http://www.nppaindia.nic.in/ceiling/press23oct17/Prices(7).pdf">http://www.nppaindia.nic.in/ceiling/press23oct17/Prices(7).pdf</a><o:p></o:p></span></div>
</div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-42075566528819828772017-07-12T22:09:00.000-07:002017-07-12T22:09:48.997-07:00#CDSCO Allows Relabeling of Old Medicines with Revised MRPs<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
<div style="text-align: justify;">
Through a recent notice, Directorate of General of Health Services, Central Drugs Standard Control Organisation (CDSCO), Ministry of Health and Family Welfare has clarified that pharmaceutical companies can relabel old stocks of their medicines with the revised Maximum Retail Prices (MRP) applicable following implementation of the Goods and Service Tax (GST) regime.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The notice implied that on receipt of representation received from FICCI dated 7.7.2017 on the subject Stickering of Pharmaceuticals as per Act and Rules relating to Goods & Service Tax (GST),this office has no objection for alteration of label (stickering) by the manufacturers under rule 104A of the Drugs and Cosmetics Rules, 1945, if required for implementation of GST subject to provisions of Legal Metrology Act & Rules and other provisions of Act and Rules relating to Goods & Service Tax.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
In a circular last week the Ministry of Consumer Affairs, Food and Public Distribution had already stated that manufacturers, packers and importers of pre-packaged commodities should declare the post GST MRPs of unsold stocks which were manufactured, imported or packed before July 1.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
There had been lot of confusion among chemist regarding selling price of medicine till now and they had been selling old stocks of medicines at their pre-GST MRPs even after implementation of GST on 1st July. Incidentally pharma companies were expected to declare the new MRPs on the batches they manufactured after July 1. Attached below are relevant notifications concerning the issue.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
</div>
<div style="display: block; font-family: "helvetica" , "arial" , sans-serif; font-size: 14px; font-stretch: normal; font-style: normal; font-variant: normal; font-weight: normal; line-height: normal; margin: 12px auto 6px auto;">
<a href="https://www.scribd.com/document/353647025/CDSCO-Notice-GST#from_embed" style="text-decoration: underline;" title="View CDSCO Notice GST on Scribd">CDSCO Notice GST</a> :</div>
<iframe class="scribd_iframe_embed" data-aspect-ratio="0.7074509803921568" data-auto-height="false" frameborder="0" height="600" id="doc_44969" scrolling="no" src="https://www.scribd.com/embeds/353647025/content?start_page=1&view_mode=scroll&access_key=key-YydktrNWkuXlHlD6tNmY&show_recommendations=true" width="100%"></iframe></div>
<div style="display: block; font-family: "helvetica" , "arial" , sans-serif; font-size: 14px; font-stretch: normal; font-style: normal; font-variant: normal; font-weight: normal; line-height: normal; margin: 12px auto 6px auto;">
<a href="https://www.scribd.com/document/353647126/Impact-of-GST-on-Unsold-Stock-of-Pre-packaged-Commodities#from_embed" style="text-decoration: underline;" title="View Impact of GST on Unsold Stock of Pre-packaged Commodities on Scribd">Impact of GST on Unsold Stock of Pre-packaged Commodities</a>:</div>
<iframe class="scribd_iframe_embed" data-aspect-ratio="0.7080062794348508" data-auto-height="false" frameborder="0" height="600" id="doc_29679" scrolling="no" src="https://www.scribd.com/embeds/353647126/content?start_page=1&view_mode=scroll&access_key=key-PHNRwQbGqXDdGrOpz9nf&show_recommendations=true" width="100%"></iframe>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-62881598196036210952017-07-07T00:41:00.001-07:002017-07-07T00:41:11.418-07:0015 Medical Devices Notified as Drugs for Price Regulation: #CDSCO<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgtOYhyphenhyphenFSnMq6YX0riUxnhu73WTgutPB5y4CddwfjK8LLuZpFxyyIVyX3WBkWCiqQDQo44R30oa9ZyCVi_Nd_hITFrPywy5HarAFMJvj7e8nYzZQb2X0rN48WGx59IUexP7Q6AMngOjPLo/s1600/Medical_Devices_NPPA.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="1143" data-original-width="1600" height="456" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgtOYhyphenhyphenFSnMq6YX0riUxnhu73WTgutPB5y4CddwfjK8LLuZpFxyyIVyX3WBkWCiqQDQo44R30oa9ZyCVi_Nd_hITFrPywy5HarAFMJvj7e8nYzZQb2X0rN48WGx59IUexP7Q6AMngOjPLo/s640/Medical_Devices_NPPA.jpg" width="640" /></a></div>
Through a recent notice, Central Drugs Standard Control Organisation (CDSCO),Directorate General of Health Services, Office of Drugs Controller General India has informed about 15 notified medical devices classifying as drugs bringing them automatically under price regulation.<br />
<br />
On a notice dated June 29, 2017, CDSCO stated that The Drugs & Cosmetics Act, 1940 is an Act to regulate import, manufacture,distribution and sale of drugs and cosmetics. It extends to the whole of India. Further, the Drugs & Cosmetics Rules, 1945 have been put in place which are updated from time to time for uniform implementation of the statutory requirements<br />
<br />
The devices intended for internal or external use in diagnosis, treatment, mitigation or prevention of disease or disorder in human beings or animals, as may be specified from time to time by the central govt by notification in official gazette, after consultation with the Board, fall under the definition of drug.<br />
<br />
The list of devices, so far are appended includes:<br />
<br />
1. Disposable Hypodermic Syringes<br />
2. Disposable Hypodermic Needles<br />
3. Disposable Perfusion Sets<br />
4. In vitro Diagnostic Devices for HIV, HbsAg and HCV<br />
5. Cardiac Stents<br />
6. Drug Eluting Stents<br />
7. Catheters<br />
8. Intra Ocular Lenses<br />
9. I.V. Cannulae<br />
10. Bone Cements<br />
11. Heart Valves<br />
12. Scalp Vein Set<br />
13. Orthopedic Implants<br />
14. Internal Prosthetic Replacements<br />
15. Ablation Device<br />
<br />
The notice further informed that the health ministry has notified Medical Devices Rules, 2017, to bringing critical medical devices like stents, orthopaedic implants and diagnostic equipment under stringent regulation,which will come into force with effect from 1st day of January, 2018.<br />
<br />
Criteria for Classification of medical devices including in vitro diagnostics have been specified in Rule 4, Chapter II of the rules which deals with regulation of Medical Devices in Indian context and in line with International Classification.<br />
<br />
“It is expected that the importers, manufacturers, distributors and supply chain personnel shall voluntarily adhere with the safety, performance and quality aspects as stated in the said medical devices Rule, 2017 for creating proper eco-system for its effective regulation.In order to facilitate the process a special cell has also been created consisting of concerned JDC (I), DDC (I) and ADC (I) to address the issues, if any.” the notice added<br />
<br />
A draft list of Medical Devices and in vitro diagnostics along with their risk based classification is annexed. Attached is the notification regarding the same.<br />
<br />
<b><a href="http://www.cdsco.nic.in/writereaddata/notice%2029_6_2017.pdf" target="_blank">Download Here</a></b></div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-9862501266000157352017-07-04T22:22:00.003-07:002017-07-04T22:22:31.031-07:00Check out #NPPA new Mobile app to verify Costs of Medicines<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgIINiSTHmxmvJoLIJoetFFFq3B0q2MQG7f0nG3KcnDwlIa6CD74-a73ZQb1AhImHMrDSoIItdX7A0ApVONukFlX3Ln6Et0Yx5Dc6RYpak3PwcFCHl5HpSFkLcyL4MU_lOcfde7jExNuGo/s1600/NPPA_GST.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="224" data-original-width="553" height="257" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgIINiSTHmxmvJoLIJoetFFFq3B0q2MQG7f0nG3KcnDwlIa6CD74-a73ZQb1AhImHMrDSoIItdX7A0ApVONukFlX3Ln6Et0Yx5Dc6RYpak3PwcFCHl5HpSFkLcyL4MU_lOcfde7jExNuGo/s640/NPPA_GST.jpg" width="640" /></a></div>
<br />
<div style="text-align: justify;">
Public will now be able to track the information regarding their medicines they have been prescribed, their availability and prices through a new application on their smart phones. A new application known as ‘Pharma Sahi Daam’ has been introduced by NPPA that will help consumers to know the prices of scheduled medicines and non-scheduled medicines which are under price regulation after the implementation of the Goods and Services Tax (GST).</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
‘Pharma Sahi Daam’ is an online search tool which will indicate the MRP of the medicines (inclusive of VAT). This app will facilitate consumers to verify whether medicines are being sold within the approved price range and also to detect any case of overpricing by pharmaceutical company/chemist.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The app, developed by NPPA, provides information on the prices of scheduled medicines that are under price regulation as well as non-scheduled medicines. It also provides information about the nearest chemists and has a list of Jan-Aushadhi stores nearby</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Apart from tracking the percentage of change in the cost of medicines, people can also register a complaint in case of overcharging of medicines on PHARMA JAN SAMADHAN website. (<a href="http://nppaindia.nic.in/redressal.html">http://nppaindia.nic.in/redressal.html</a>). </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Helpline number: 1800111255 </b></div>
<div style="text-align: justify;">
<b>Whatsapp number; 9695736333 </b></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
To download the app click on the link given below. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<a href="https://play.google.com/store/apps/details?id=com.nic.app.searchmedicineprice">https://play.google.com/store/apps/details?id=com.nic.app.searchmedicineprice</a></div>
<br />
<br /></div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-66076974207375749822017-07-04T02:26:00.001-07:002017-07-04T02:26:43.952-07:00#NPPA fixes ceiling prices of 814 scheduled Formulations<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhzHJTpgv_GdGLk2G6zrpT_h5qRXDycYR26d6xNgKScYBT-Bl9qDRKCwDH-3Gt_m3vkERZ97N4pcHSlyyFZCJEZjinH87t06KTszwLRsJTgdiBBSZrOVuWtw5axffiyRFsgBvdkXSJse-Q/s1600/NPPA_GST.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="261" data-original-width="397" height="262" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhzHJTpgv_GdGLk2G6zrpT_h5qRXDycYR26d6xNgKScYBT-Bl9qDRKCwDH-3Gt_m3vkERZ97N4pcHSlyyFZCJEZjinH87t06KTszwLRsJTgdiBBSZrOVuWtw5axffiyRFsgBvdkXSJse-Q/s400/NPPA_GST.jpg" width="400" /></a></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
New ceiling prices of 814 scheduled formulations became effective from today with drug pricing regulator NPPA fixing the cap in sync with the new GST regime. These formulations include medicines used for treatment of cancer, HIV, diabetes and infections among others. In a notification, National Pharmaceutical Pricing Authority (NPPA) said the fixation, revision of the prices of 814 scheduled formulations were done under Schedule-I under Drugs (Price Control) Amendment Order, 2016 under DPCO, 2013. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Union Chemicals and Fertilisers Minister Ananth Kumar had said yesterday that NPPA will work out a mechanism ensuring patients do not pay more for drugs whose prices are expected to go up after the GST implementation. NPPA has already said that prices of around 78 per cent of ‘actively used’ drugs will remain unaffected after the rollout of the Goods and Services Tax (GST), which took effect today. “Price of drugs where partial increase is expected due to roll out of GST will not be passed on to consumers as NPPA is working out a mechanism in this regard,” Kumar had told reporters. He had further stated NPPA is working out a mechanism “to subsume for partial increase of retail prices of some drugs”. Kumar reiterated that “prices of life saving drugs and essential drugs rates will come down with reduction in GST rate”. The regulator had earlier indicated that the prices of majority of essential drugs would increase by up to 2.29 per cent when the GST regime kicks in. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<div>
The government has fixed GST rate of 12 per cent on most of the essential drugs as against the earlier tax incidence of around 9 per cent. To check out the list of fix prices schedule formulations click on the following links </div>
<div>
<br /></div>
<div>
<a href="http://www.nppaindia.nic.in/ceiling/press30June17/so27042017e81-30-06-17_1.pdf" target="_blank">http://www.nppaindia.nic.in/ceiling/press30June17/so27042017e81-30-06-17_1.pdf </a><a href="http://www.nppaindia.nic.in/ceiling/press30June17/01so27042017e2-30-06-17_2.pdf" target="_blank">http://www.nppaindia.nic.in/ceiling/press30June17/01so27042017e2-30-06-17_2.pdf </a><a href="http://www.nppaindia.nic.in/ceiling/press30June17/01so27042017e2-30-06-17_3.pdf" target="_blank">http://www.nppaindia.nic.in/ceiling/press30June17/01so27042017e2-30-06-17_3.pdf </a></div>
<div>
<span style="background-color: #f3f3f3; font-family: Arial; font-size: 14px; text-align: start;"><a href="http://www.nppaindia.nic.in/ceiling/press30June17/01so27042017e2-30-06-17_4.pdf" target="_blank">http://www.nppaindia.nic.in/ceiling/press30June17/01so27042017e2-30-06-17_4.pdf </a><a href="http://www.nppaindia.nic.in/ceiling/press30June17/01so27042017e2-30-06-17_5.pdf">http://www.nppaindia.nic.in/ceiling/press30June17/01so27042017e2-30-06-17_5.pdf</a> <a href="http://www.nppaindia.nic.in/ceiling/press30June17/01so27042017e2-30-06-17_6.pdf">http://www.nppaindia.nic.in/ceiling/press30June17/01so27042017e2-30-06-17_6.pdf</a></span><br style="background-color: #f3f3f3; font-family: Arial; font-size: 14px; margin: 0px; padding: 0px; position: relative; text-align: start; word-wrap: break-word;" /></div>
</div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-21793319718374328752017-06-29T22:48:00.003-07:002017-06-30T00:23:58.536-07:00Before #GST, #NPPA Releases Ceiling Price of 761 Medicines<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
<div style="text-align: justify;">
Drug price regulator NPPA on Tuesday announced provisional ceiling prices of 761 medicines, including anti-cancer, HIV, diabetes and antibiotic, with a majority being reduced ahead of the GST implementation. The National Pharmaceutical Pricing Authority (NPPA) said however that the actual increase or decrease in prices after the roll out of new indirect tax regime is expected to be in be in the range of 2-3 per cent depending on states. “In order to facilitate smooth implementation of GST </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b><a href="http://www.nppaindia.nic.in/order/List-27-06-17.pdf" target="_blank">Download Complete List</a></b></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Or View : </div>
</div>
<iframe class="scribd_iframe_embed" data-aspect-ratio="1.414442700156986" data-auto-height="false" frameborder="0" height="800" id="doc_62215" scrolling="no" src="https://www.scribd.com/embeds/352581502/content?start_page=1&view_mode=scroll&access_key=key-VYxiEqmTqAsSRQyiUydj&show_recommendations=true" width="600"></iframe></div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-34401172150386513132017-06-28T22:28:00.003-07:002017-06-28T22:28:54.875-07:00#FSSAI drafts notification related to the purity of Steviol Glycoside<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh5u3XbazuWRm_NpKH3N_i2cDNLfc7T93kVOdxet-myujL8ZQ80he_2P83HewSEuQ__VCQaAVH6YTL02OzFxj5ShVbJfhjQI3s5HfDm2MbsocotVkpuVRr8cFVpRWWmVkGFFOea5f_b6sU/s1600/Steviol-glycosides.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="390" data-original-width="746" height="209" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh5u3XbazuWRm_NpKH3N_i2cDNLfc7T93kVOdxet-myujL8ZQ80he_2P83HewSEuQ__VCQaAVH6YTL02OzFxj5ShVbJfhjQI3s5HfDm2MbsocotVkpuVRr8cFVpRWWmVkGFFOea5f_b6sU/s400/Steviol-glycosides.jpg" width="400" /></a></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
In February 2015 the FSSAI had drafted regulations related to the use of Steviol Glycoside in the Food Safety and Standards (Food Product Standards and Food Additives) Regulations 2011 under ‘Artificial Sweetener’. Through a notification dated 20 June 2017 the FSSAI has asked stakeholders for their view comments and suggestions related to the purity of Steviol Glycoside within 60 days beginning 20 June 2017.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The FSSAI has already approved the use of Steviol Glycoside, as a non-nutritive sweetener in various foods and has also drafted the regulation along with the standards. FSSAI now wishes to make some substitutions in the earlier proposed regulations. The two substitutions the FSSAI wishes to make in the standards for Steviol Glycoside in the draft regulations are as follows</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Under ‘PURITY’ FSSAI would like to substitute PURITY to the words and figures Assay/purity – Not less than 95 per cent of the total of Steviol Glycosides on the dried basis</b></div>
<div style="text-align: justify;">
<b><br /></b></div>
<div style="text-align: justify;">
<b>Total ash not more than per cent to be substituted with the words and figures Total ash – Not more than 1 per cent </b></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
FSSAI has approved the use of Steviol Glycoside in chewing gum and as a Table Top Sweetener in tablet, liquid and powder forms. Steviol Glycoside can serve as a sugar substitute for diabetics as it does not induce a glycaemic response when ingested. FSSAI has also permitted the use of Steviol Glycoside in dairy based flavoured drinks, dairy based deserts like ice cream, frozen desserts, cream toppings, yoghurt, fruit nectars, non-alcoholic and non-carbonated water based beverages ices, lollies and edible ice, jams, jellies, marmalades, ready to eat cereals, carbonated water and soft drink concentrates. The use of Steviol Glycoside in these foods has been regulated and their use must be within the permitted limitations.</div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-70395568945732875402017-06-28T20:27:00.001-07:002017-06-28T20:29:01.253-07:00#FSSAI Notifies Draft Amendment in FSS (Import) Regulations 2017<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEitvUiYk2wHcHKcjnI3NxT-vRoxpijNOHzybSCYZ0vWlnEH4GUW-RGnnPXFmeMezxl2RfGgJA0WXOX9J_UVfr6kAHnOfnSANXB3KfWAmQA2RkgBFhV2epmIHnESfcWvEcLc5mnIDt-leb0/s1600/FSSAI.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="960" data-original-width="1280" height="300" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEitvUiYk2wHcHKcjnI3NxT-vRoxpijNOHzybSCYZ0vWlnEH4GUW-RGnnPXFmeMezxl2RfGgJA0WXOX9J_UVfr6kAHnOfnSANXB3KfWAmQA2RkgBFhV2epmIHnESfcWvEcLc5mnIDt-leb0/s400/FSSAI.JPG" width="400" /></a></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Through a notification dated 20 June 2017 the Food Authority has invited comments, views and suggestions from stakeholders on the draft notification related to amendment in Food Safety and Standards (Import) Regulations, 2017. The FSSAI had drafted the Food Safety and Standards (Import) Regulations 2017 in March 2017. The amendments sought to be made are as follows</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
In Chapter II of the regulation, relating to ‘Licensing of Food Importers’ under regulation number 3 the sub-regulation (2) is proposed to be omitted. This sub-regulation reads as follows “No article of food shall be cleared from the custom unless it has a valid shelf life of not less than sixty per cent at the time of import”</div>
<div style="text-align: justify;">
On omission of the above there will be changes in sub-regulation (3) also which will now become sub-regulation (2) and will read as For the purpose of sub-regulation (1), the Food Importer shall register himself with the Directorate General of Foreign Trade and possess valid Import-Export Code.”</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The next change is In Chapter –III, relating to ‘Clearance of Imported Food by the Food Authority’.</div>
<div style="text-align: justify;">
The sub-regulation omitted from Chapter II will be inserted in Chapter III after sub-regulation number (5) and will be sub-regulation (6) and read as “No article of food shall be cleared from the custom unless it has a valid shelf life of not less than sixty per cent or three months whichever is less at the time of import.”</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
In Chapter VII, relating to ‘Scheme for Risk based Food Import Clearance’, in regulation number 11, for sub-regulation (2) Sub-regulation will have two clauses (a) and (b) which will be used for ‘risk based framework’ and ‘risk based inspection process’ for clearance of imported articles of food.</div>
<div style="text-align: justify;">
Clause (a) is present in the regulation and reads as</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
(a) The Food Safety and Standards Authority of India shall profile the Importer, Custom House Agents, imported product, manufacturer of the imported product, country of origin, source country of the consignment, port of entry, compliance history and any other parameters deemed fit for profiling the risk associated with the commodity.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
After clause (a) the FSSAI proposes to insert the following to sub-regulation</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
(b) The importer shall submit sanitary export certificate from authorized agencies in exporting countries for certain food categories as may be specified by the Food Authority from time to time.</div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-2103336637719839802016-08-03T21:21:00.001-07:002016-08-03T21:21:03.237-07:00#GST : Benefits to the Pharmaceutical Industry<div dir="ltr" style="text-align: left;" trbidi="on">
<div style="text-align: justify;">
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharmaceutical manufacturers by rationalising the tax structure and optimising distribution. Even a 2 per cent reduction in production or distribution cost will add to the profits by over 20 per cent. It could be the single biggest shot in the arm for the Pharmaceutical industry and create competitive advantage for those who move early.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The Indian Pharmaceutical industry with a domestic turnover of over USD 15 billion is amongst the largest producers of pharmaceutical products in the world (by volume). While the sector has been witnessing high growth over the past decade it has been burdened with diminishing margins. The domestic industry is facing pressures of increasing span of price control on account of changing regulations, price erosion with more generics and increasing competition added by lack of R&D productivity and limited new molecules. Multistage taxation in the pharmaceuticals industry ie, Customs duty on imports, Central excise duty on manufacture, Central Sales Tax (CST)/Value Added Tax (VAT) on sale of goods, Service tax on provision of services and levies such as entry tax, octroi, cess by the State or municipalities; loss of credit of tax paid, adds to the inefficiencies and cost. GST will help in rationalising the tax structure and could be the single biggest shot in the arm for the Pharmaceutical sector.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>What is Goods and Services Tax (GST)?</b></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
GST is an evolution of the current tax regime, transforming the complex and cascading structure into a unified value added system of taxation. Under this, a value added tax would be levied at every point of the supply chain providing for credit for any/all taxes paid previously.Keeping in line with the governance structure of the country GST would be levied simultaneously by the Centre and State (CGST and SGST respectively). All essential characteristics in terms of its structure, design applicability, etc. would be common between CGST and SGST, across all states.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
GST is expected to replace most of the current applicable indirect taxes as listed in Exhibit 1.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Benefits to the Pharmaceutical Industry:</b></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Implementation of GST will have significant impact and will change the manner in which business is carried out in comparison with the existing ways.The application of a single tax rate across all goods and service will result in redistribution of taxes across all categories. This will lead to a reduction in taxes on manufactured goods and thereby impacting the pricing of the final product.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The integration of tax on Goods and Services through GST would provide the additional benefit of providing credit for service tax paid by manufacturers. Both CENVAT & VAT, which are being levied at present, give tax credit to the manufacturer for the tax paid for raw materials (hence a tax is charged only on the value added by the manufacturer). More often than not, there are various services including logistics involved in getting the input material to its final customers. Service tax is paid on the cost of such services too. With the implementation of GST, cost of any service, including logistics, will be considered as value add, and the manufacturer will get tax credit for the service tax paid.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The biggest advantage to the industry would be that of reduction in transaction cost, with an immediate impact coming from the discontinuance of CST. The multistage taxation along with the inability to take full benefit of the CENVAT credit /refund has been an issue for the industry. With central GST expected to be a single rate for goods and services, going forward credit accumulation may not be an area of concern. Furthermore, if the legislation provides for carrying forward of the unutilised credit this would be an additional boost to the industry.</div>
<div style="text-align: justify;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg8AAJBh8wQZahrIBudGEauADSS2lv8Z9oi414LrhVHMp-OZzJXHTeRnNI4YtJzoVYUNJqPwJ3xxb1QzAyhQY8LNOqk7NOAnrOpHsBTCavCoJjsNwa0nHd7wHaPmVPACPJicRUNGj0_bS0/s1600/imgnew1.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg8AAJBh8wQZahrIBudGEauADSS2lv8Z9oi414LrhVHMp-OZzJXHTeRnNI4YtJzoVYUNJqPwJ3xxb1QzAyhQY8LNOqk7NOAnrOpHsBTCavCoJjsNwa0nHd7wHaPmVPACPJicRUNGj0_bS0/s1600/imgnew1.jpg" /></a></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
India a single common market: Under GST inter-state sales transactions between two dealers would be cost equivalent and comparable with stock transfers/branch transfers. Inter-state transactions would become tax neutral, making India one single common market no longer divided by state borders (Exhibit 2). This will result in lower cost which can add to margins or can be passed on to customers.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Opportunity to explore alternate distribution models: Organisations will be able to explore different distribution models such as setting up mother warehouses and regional distribution hubs and consider stepping away from traditional C&F and distributor based models currently adopted. This will lead to logistics and distribution to evolve as a competitive advantage through improved service levels, faster turnaround times and better fill rates at lower costs. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Rationalisation of Warehouses and Transport network: GST would do away with the existing penalties on inter-state sales transactions and facilitate consolidation of vendors and suppliers, eliminating the need to have state wise warehouses to avoid CST and the associated paperwork. This will enable companies to consolidate warehouses, rationalise their networks and take advantage of economies of scale, improved efficiencies, better control and reduction in inventory (ie, working capital deployed in the business). For example: By setting up a large warehouse in a place like Zirakpur, a large logistics hub with good infrastructure, a company can serve markets across the states of J&K, Himachal, Punjab, Uttrakhand and Haryana as against having five different warehouses to serve these markets in the current scenario. </div>
<div style="text-align: justify;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj_mmG8IeCrd-yhZ-k3NknqGnRghmGEWFaAVtZ7ovPdwnE-NguIQ8FcXtTCKG2v11Tg5SLrf2b2zX-BMsIzsIxhNkjCAm7zlsesFP1gSjrnIJc_C18euEQ162IPe_kLVfY6r-onZyhJhGo/s1600/imgnew2.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj_mmG8IeCrd-yhZ-k3NknqGnRghmGEWFaAVtZ7ovPdwnE-NguIQ8FcXtTCKG2v11Tg5SLrf2b2zX-BMsIzsIxhNkjCAm7zlsesFP1gSjrnIJc_C18euEQ162IPe_kLVfY6r-onZyhJhGo/s1600/imgnew2.jpg" /></a></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Furthermore, the pharmaceutical sector currently enjoys various location based tax holidays on its manufacturing activities. Under the proposed structure of GST, such area based exemption will be done away with. However, taking into account past precedents suitable work around/refund process would be constituted to ensure that any existing hubs do not get impacted and continue to get the agreed benefits. However, the challenges faced in distributing from these remote locations could be addressed by designing logistics efficient networks of mother and daughter warehouses to ensure optimisation of cost and superior availability of products. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
While the qualitative benefits arising out of GST are well established, there is a definite impact to economics of companies as well. Logistics cost accounts for nearly 13-14 per cent of our GDP. Of the total logistics cost transportation contributes ~35 per cent, warehousing & storage ~10 per cent, inventory holding cost ~25 per cent and other inefficiencies’ make up the balance 30 per cent. Implementation of GST and alignment of a firm’s supply chain to it will directly help in reducing cost on transportation, warehousing and inventory holding by 5-8 per cent, 10-12 per cent and upto 28 per cent respectively for each of the cost heads, leading to an overall savings in the range of 10-12 per cent of the total logistics cost.</div>
<div style="text-align: justify;">
<b><br /></b></div>
<div style="text-align: justify;">
<b>Looking Forward:</b></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The government has already begun the process of getting the necessary consensus from all the stake holders to pave the way for implementing this landmark tax reform. Though the exact details are still sketchy, the structure and deliverables have been clearly laid down for all to see. The government has set itself an ambitious target to roll it out by July 2015. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
As Indian pharmaceuticals companies look forward to revenue growth on one side and the need to reduce costs, GST offers a great opportunity to revisit their Supply Chain & distribution strategy to develop an agile, customised and cost-efficient supply chain. Companies need to act now to assess the impact of GST on their businesses and functions and develop an action plan and road map for the future. Those who move early are likely to gain an advantage on cost and service levels over their competitors and deliver a better value proposition to the customer. </div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-3917502668000222512015-09-15T03:43:00.000-07:002015-09-15T03:43:15.044-07:00Integral 3D Barcode Helps Beat Counterfeiters<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEifIMeBaCgWFR6ss36TMCORr0Z5vYO2HJuaXyhp78hFd2IzsRjdWlMhGgI1zDHvpVRfe2SouHSrjp0vNNypoIKZUN5JlWRu2j1-8GFTxBLHPPonbyCqR01Pz9ereDHWYb4unAEVmfEyqpE/s1600/3D_Barcode.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="205" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEifIMeBaCgWFR6ss36TMCORr0Z5vYO2HJuaXyhp78hFd2IzsRjdWlMhGgI1zDHvpVRfe2SouHSrjp0vNNypoIKZUN5JlWRu2j1-8GFTxBLHPPonbyCqR01Pz9ereDHWYb4unAEVmfEyqpE/s400/3D_Barcode.jpg" width="400" /></a></div>
<div style="text-align: justify;">
The first 3D barcode which can be built into products during manufacture has been developed by engineers based in Yorkshire, UK.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Sofmat, which developed the technology with engineers from the University of Bradford, says it has particular relevance for pharmaceutical, automotive and high value consumer products.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The anti-counterfeit marker is virtually invisible to the naked eye and impossible to detect by touch. It can be read using a laser scanner, allowing anything from phones to pills to be tracked and verified as authentic.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The 3D barcode is made up of tiny indentations in the surface of the product, created by pins which are integrated into its mould. Using micro actuators, the pins can be set at different heights, each step corresponding to either a letter (A–Z) or a number (0–9). The prototype, developed with funding from Innovate UK, works with a four-pin array, enabling more than 1.7 million different configurations.</div>
<div style="text-align: justify;">
<br /></div>
<iframe allowfullscreen="" frameborder="0" height="315" src="https://www.youtube.com/embed/ZNKbigP1eYU" width="560"></iframe>
<div style="text-align: justify;">
<br />
'The system enables very small displacements to be made in each pin – each step being just 0.4 microns, 100th of the width of a human hair,' explained Ben Whiteside from the University of Bradford. 'These have to be set with a very high accuracy, and with sufficient force so their position is maintained during the manufacturing process. While our system has been developed initially for products made from plastics or composites through injection moulding, it could also be used to stamp or emboss the code onto a product.'</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Estimates for the total value of fakes sold worldwide each year are US$1.8 trillion. Most anti-counterfeit devices are stuck onto the product or its packaging after manufacture, making them easy to copy. Because the 3D barcode is an integral part of the product itself it is very difficult to reproduce.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
'A 3D barcode allows much more complexity than existing anti-counterfeit systems,' said Sofmat Director Phil Harrison. 'You can have multiple configurations, different codes on each individual product and additional details such as patterns on the heads of the pins themselves, making copying the code extremely difficult. For the first time the same technology and coding can be used on bulk packaging, individual packaging and on the actual product, making it much harder to create and ship fake products.'</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The system has been verified in the laboratory using high-tech scanning devices including a white light interferometer and a laser-scanning confocal microscope to characterise the surface of the coded ‘product’ to ensure the code is accurately reproduced. A laser scanner is currently in development that will be able to read the code and wirelessly transmit the result via an app to either a phone or tablet.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The patented technology is already generating interest from the pharmaceutical sector, where counterfeiting is a serious issue. Many pharma companies are now developing moulded tablets, produced using an injection-moulding process, into which a 3D barcode could be incorporated.</div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-33137118449699717512014-12-11T00:23:00.002-08:002014-12-11T00:23:55.173-08:00Ranbaxy Received Warning Letter from German Regulators<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg7lvWr9vi3oniToaMR-wyfumyH5ze4LWwKnNTVDFA_kVvr72rZJtBH0taYAJ0A1VMRFO1AXM4Y5hzjC1Vnpk-TM_ZlakybNh-gtc3G2LULJYvlvBzqskvxQwFikXeGfsHC8_A9XXVvi6A/s1600/ranbaxy.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg7lvWr9vi3oniToaMR-wyfumyH5ze4LWwKnNTVDFA_kVvr72rZJtBH0taYAJ0A1VMRFO1AXM4Y5hzjC1Vnpk-TM_ZlakybNh-gtc3G2LULJYvlvBzqskvxQwFikXeGfsHC8_A9XXVvi6A/s1600/ranbaxy.jpg" /></a></div>
<div style="text-align: justify;">
Recently Ranbaxy has faced a lot of criticism and received warning letters from western regulators such as USFDA regarding non-compliance with GMP (Good Manufacturing Practices). Ranbaxy has received warning letter from another regulator i.e German regulator for not complying with GMP.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
According to The National Competent Authority known as Bezirksregierung Koln“Ranbaxy does not comply with the Good Manufacturing Practice Requirements referred to in the GMP Directive from the European Commission”. The regulator said that it revealed “unsatisfactory investigations into medial trials failures” along with deficiencies with Ranbaxy’s design and operation of its clean rooms as well as controls for the preparation and sterilization of its equipment and controls for its aseptic filling.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The National Competent Authority also said that Ranbaxy’s sterile products are non-compliant and its new GMP certificate for its Dewas India site does not include sterile products. Germany’s regulators have issued a non compliance report for the Dewas Facility where Ranbaxy manufactures cephalosporin antibiotics after an inspection in June 2014 for not complying with Good Manufacturing Practices.</div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-35903820918335620462014-09-10T21:56:00.001-07:002014-09-10T21:56:53.159-07:00Three officials suspended for certifying drug as 'qualified'<div dir="ltr" style="text-align: left;" trbidi="on">
<div style="text-align: justify;">
Bengaluru, India 9 Sept 2014: The State Drugs Controller has recommended suspension of three officials – Junior Science Officer, Government Analyst and Chief Scientific Officer – for allegedly certifying a drug as ‘qualified’ despite negative report in the test and analysis.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Health and Family Welfare Department Principal Secretary N Sivasailam has submitted before Upalokayukta that the case will be entrusted to Lokayukta for disciplinary enquiry as per service rules.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
An enquiry conducted by the Upalokayukta Justice Subhash B Adi had found that drug samples of Ccliya (Clomifene Citrate tablets) were certified as ‘qualified’ despite negative report in the test and analysis.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The complaint was that Chief Scientific Officer (CSO) Sudha Swamy had pressurised Government Analyst Mohammed Saifuddin Rubbani and Junior Scientific Officer Girish M K to prepare a positive report in the testing and analysis of the drug.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The drug samples of Ccliya, used in fertility treatment, was sent back to Government Analyst for repetition of test and analysis. After three repeated tests, CSO approved the report and the message was made known to retailers, wholesalers, manufacturers to prevent the sale of the drug.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
However, one more test was conducted and the report was dispatched as “test passed.’’ Drugs Controller Raghurama Bhandary on Tuesday submitted a report stating all the three staff of the State Drugs Testing Laboratory were responsible for arbitrary and negligent testing.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
“She (Sudha Swamy) has failed to report to higher authorities regarding approval of the test report as Not of Standard Quality and changing it to Standard Quality even after Not of Standard Quality report information had reached the public domain by way of SMSes and web publication,” the report said.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Upalokayukta Justice Subhash B Adi said the Principal Secretary has assured action within 15 days.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
“In view of the submission by the Principal Secretary for Health and Family Welfare Department and promising action to be taken both of disciplinary enquiry as well as criminal proceedings if necessary against the officers, the matter has been posted for further hearing on September 30,” he said.</div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-53452650751304596042014-05-30T08:51:00.000-07:002014-05-30T08:51:05.106-07:00USFDA Seized Illegal Prescription Drugs Supplied From Online Sources.<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjizk8xwZn1EKD337YJqDMhDiiJ4TdRg8hx-xzGsrpCfbHaWeTxreRmNtFzMjy4fajgyVJcYch0ETFUtaSH6J2WBi9MVsVMF3Bn7wBhfWGtmNWcRWmxzUjt0kmvP0PCCxUZnB69RLMBtfo/s1600/illegal+drugs+websites.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjizk8xwZn1EKD337YJqDMhDiiJ4TdRg8hx-xzGsrpCfbHaWeTxreRmNtFzMjy4fajgyVJcYch0ETFUtaSH6J2WBi9MVsVMF3Bn7wBhfWGtmNWcRWmxzUjt0kmvP0PCCxUZnB69RLMBtfo/s1600/illegal+drugs+websites.jpg" height="175" width="320" /></a></div>
<div style="text-align: justify;">
The U.S. Food and Drug Administration cracked down this week on illegal online websites that market potentially dangerous, unlicensed prescription drugs to U.S. consumers. The crackdown took place in support of the 7th annual International Internet Week of Action (IIWA) under the INTERPOL-sponsored Operation Pangea VII.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Together with the U.S. Customs and Border Protection (CBP), the FDA examined U.S. based international mail facilities and seized illegal prescription drugs supplied from online sources. A total of 19, 618 packages containing drugs presumably from Australia, UK, Canada, and New Zealand were seized. Further inspection revealed that the packages contained unapproved or possible counterfeit drugs from India, China, Mexico, Australia, and New Zealand, among others.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Inspection of mail facilities in Los Angeles, New York, and Chicago resulted in the detention or seizure of 583 packages. These contained insulin, estrogen, human chorionic gonadotropin, and sildenafil citrate, among others. The FDA notified Internet service providers and domain name registrars about the nearly 2,000 websites selling pharmaceutical products in violation of the U.S. law.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Douglas Stearn, director of the FDA’s Office of Enforcement and Import Operations, said, “When consumers buy prescription drugs from outside the legitimate supply chain, they cannot know if the medicines they receive are counterfeit or even if they contain the right active ingredient in the proper dosages. Consumers have little or no legal recourse if they experience a reaction to the unregulated medication or if they receive no therapeutic benefit at all.” Stearn added that these online illegal pharmacies can also lead to credit card fraud, digital viruses, or identity theft.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
“Many illegal online pharmacies use slick website templates and empty guarantees to convince U.S. consumers that the inexpensive drugs they sell are the exact same prescription drugs that are dispensed in the U.S. The FDA will continue to leverage our resources and strengthen our national and international partnerships to shed light on these Internet-based fraudulent activities which target consumers,” said Philip J. Walsky, acting director of the FDA‘s Office of Criminal Investigations.</div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-1019499583408678821.post-82132170176654905612014-05-14T01:01:00.000-07:002014-05-14T01:01:01.167-07:00Track & Trace System for Domestic Drug Supply Chain In Nine Months<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj_3sNe4-x1EGCfGUlMCtOwzW0rjnxm8SqoBD3muQV55KW4znRyhGoDmjVrgU8_24fy6OG277gW24NNKafDkKdexfmXS1JuVlzavWfPjXYuTbu2uHlQLRNlvvUeS19wv0PiMAXME9tMsW4/s1600/tt.png" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj_3sNe4-x1EGCfGUlMCtOwzW0rjnxm8SqoBD3muQV55KW4znRyhGoDmjVrgU8_24fy6OG277gW24NNKafDkKdexfmXS1JuVlzavWfPjXYuTbu2uHlQLRNlvvUeS19wv0PiMAXME9tMsW4/s1600/tt.png" /></a></div>
<div style="text-align: justify;">
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one year as the National Informatics Centre (NIC) is on the task.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The NIC is preparing a software and it is likely to be finalised and implemented in nine months, going by the latest inputs to the commerce ministry. Once implemented, it will be able to track the drugs all throughout the domestic supply chain, senior official from the commerce ministry disclosed.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Apart from helping the domestic market, the system will be used to ensure the quality of drugs being exported from the country upto the point of port. This will work as the technological authentication, along with the bardcoding system now in force for exports on secondary and tertiary packaging.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Though the report by a task force set up by the health ministry was submitted way back in 2012, no final decision was taken for a long time on its implementation. Now the government is learnt to have decided to go for the mechanism that would help any customer to trace all details of the product by reading the barcode with the help of devices like mobile.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
However, the move has been faced with stiff opposition from a section of the industry and also the agencies like the National Pharmaceutical Pricing Authority (NPPA) which felt that the system was found to be inadequate and less comprehensive.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The task force, headed by Dr H G Koshia, had recommended the adoption of SMS model and unique identification code as an ideal method for the track and trace system as it was found to be more viable and affordable to the industry.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
“The task force, after detailed deliberation on the issue of track and trace and UID authentication, was of the considered view that in a country like India where multiple products are manufactured by a large number of companies, this would be a boon if applied. Initially there would be problems of application due to various reasons including financial and technical issues, but a beginning should be made so that ultimately the benefits of the system is available to all,” the task force said.</div>
</div>
Unknownnoreply@blogger.com0